Provectus Biopharmaceuticals, Inc. (PVCT): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$30.4K
Year ended 2017-12-31
-24.5%
3-year compound annual growth
+13.9%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2017-12-31 | $30.4K | n/a | 2019-03-07, From 2017-01-01 |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | $6.1K | -91.3% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $70.6K | +961.5% | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | $6.7K | -58.1% | 2016-03-30, From 2013-01-01 |
| 2012-12-31 | $15.9K | +158.4% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $6.1K | n/a | 2014-03-13, From 2011-01-01 |
| No annual figure between 2009-12-31 and 2011-12-31. | |||
| 2009-12-31 | $5.8K | n/a | 2012-03-14, From 2009-01-01 |